Possibility of HIV-1 protease inhibitors-clinical trial drugs as repurposed drugs for SARS-CoV-2 main protease: a molecular docking, molecular dynamics and binding free energy simulation study

Ancy Iruthayaraj, Mugudeeswaran Sivanandam, P. Kumaradhas

Journal of Biomolecular Structure and Dynamics · 2020 · 25 citations · 41 references

DOIFull text

Open access

Concepts

Abstract

enzyme and it may be suitable for the drug repurposing of COVID-19 and further drug designing.Communicated by Ramaswamy H. Sarma.

References

41